Literature DB >> 17487741

Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway.

Hu Jie1, He Donghua, Xue Xingkui, Gao Liang, Wu Wenjun, Han Xiaoyan, Cai Zhen.   

Abstract

Homoharringtonine has been shown to lead to apoptosis of leukemic cells in several studies. Here we showed that the endoplasmic reticulum (ER) may be the initial site of apoptotic signal induced by homoharringtonine in MUTZ-1 cells. After incubation with homoharringtonine, the percentage of apoptotic MUTZ-1 cells increased in a time-dependent manner, Ca(2+) translocated from ER pool to cytosol, the mitochondrial membrane potential decreased, and Bid protein translocated from ER to mitochondria. The activation of ER stress-associated proapoptotic factor CHOP and ER chaperones BiP and XBP1 genes followed by cleavage of caspase-3 but not caspase-4 protein were also observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487741     DOI: 10.1080/10428190701216360

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine.

Authors:  Cai Xiu; Xiao Li; Lingyun Wu; Feng Xu; Qi He; Zheng Zhang; Dong Wu; Luxi Song; Jiying Su; Liyu Zhou; Youshan Zhao; Ying Tao; Chunkang Chang
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-26       Impact factor: 4.553

Review 2.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

3.  Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.

Authors:  Feng Xiao; Ying Li; Weilai Xu; Liangshun You; Chunmei Yang; Hui Liu; Wenbin Qian
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

4.  A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome.

Authors:  N Daver; A Vega-Ruiz; H M Kantarjian; Z Estrov; A Ferrajoli; S Kornblau; S Verstovsek; G Garcia-Manero; J E Cortes
Journal:  Eur J Cancer Care (Engl)       Date:  2013-05-23       Impact factor: 2.520

5.  Dual involvement of caspase-4 in inflammatory and ER stress-induced apoptotic responses in human retinal pigment epithelial cells.

Authors:  Zong-Mei Bian; Susan G Elner; Victor M Elner
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

Review 6.  Cephalotaxus Alkaloids.

Authors:  Joëlle Pérard-Viret; Laith Quteishat; Rana Alsalim; Jacques Royer; Françoise Dumas
Journal:  Alkaloids Chem Biol       Date:  2017-08-16

Review 7.  Homoharringtonine and omacetaxine for myeloid hematological malignancies.

Authors:  Shuqing Lü; Jianmin Wang
Journal:  J Hematol Oncol       Date:  2014-01-03       Impact factor: 17.388

8.  The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.

Authors:  Xia Li; Xiufeng Yin; Huafeng Wang; Jiansong Huang; Mengxia Yu; Zhixin Ma; Chenying Li; Yile Zhou; Xiao Yan; ShuJuan Huang; Jie Jin
Journal:  Oncotarget       Date:  2017-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.